Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The luteinizing hormone receptor (LHR), also known as the luteinizing hormone/choriogonadotropin receptor (LHCGR), is a member of the glycoprotein hormone receptor subfamily within the superfamily of G protein-coupled receptors (GPCRs). It is essential for reproductive processes, including gonadal steroidogenesis, oocyte maturation and ovulation in females, and male sex differentiation. Mutations or dysregulation can result in various pathologies, including infertility, precocious puberty, and certain neoplasms.
Ligand binding induces conformational change, activates G proteins (primarily Gs), leading to increased cAMP production and downstream signaling cascades.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Luteinizing Hormone Receptor (LHR).